Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Cardiomyopathies (D009202)
Parent Node:
expand
Genetic Diseases, X-Linked (D040181)
Parent Node:
expand
Glycogen Storage Disease (D006008)
Parent Node:
expand
Mental Retardation, X-Linked (D038901)
..Starting node
..expand
Glycogen Storage Disease Type IIb (D052120)

       Child Nodes:



 Sister Nodes: 
..expandAbidi X-linked mental retardation syndrome (C535556)
..expandAdrenoleukodystrophy (D000326) Child4
..expandAldred syndrome (C537046)
..expandAllan-Herndon-Dudley syndrome (C537047)
..expandArena syndrome (C537428)
..expandArmfield X-Linked Mental Retardation Syndrome (C564551)
..expandAtkin syndrome (C538195)
..expandATR-X syndrome (C538258)
..expandBorjeson-Forssman-Lehmann syndrome (C536575)
..expandBrooks-Wisniewski-Brown Syndrome (C563154)
..expandChromosome Xp11.3 Deletion Syndrome (C564481)
..expandCK SYNDROME (OMIM:300831)
..expandClark-Baraitser syndrome (C536208)
..expandClassical Lissencephalies and Subcortical Band Heterotopias (D054221) Child5
..expandCoffin-Lowry Syndrome (D038921)
..expandCowchock syndrome (C536450)
..expandCreatine deficiency, X-linked (C535598)
..expandEncephalopathy, Neonatal Severe, Due To Mecp2 Mutations (C566878)
..expandFaciogenital Dysplasia with Attention Deficit-Hyperactivity Disorder (C564427)
..expandFragile X Syndrome (D005600) Child3
..expandGlycogen Storage Disease Type IIb (D052120)
..expandLesch-Nyhan Syndrome (D007926) Child1
..expandLubs X-linked mental retardation syndrome (C537723)
..expandLujan Fryns syndrome (C537724)
..expandMEHMO syndrome (C537451)
..expandMenkes Kinky Hair Syndrome (D007706) Child1
..expandMental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia (C567466)
..expandMental Retardation with Psychosis, Pyramidal Signs, and Macroorchidism (C564724)
..expandMental retardation X-linked syndromic 7 (C537449)
..expandMental retardation X-linked, South African type (C537450)
..expandMental Retardation, X-Linked 1 (C567906)
..expandMental retardation, X-linked 14 (C537454)
..expandMental Retardation, X-Linked 16 (C563139)
..expandMental Retardation, X-Linked 17 (C563140)
..expandMental Retardation, X-Linked 19 (C563141)
..expandMental Retardation, X-Linked 2 (C563135)
..expandMental Retardation, X-Linked 20 (C563142)
..expandMENTAL RETARDATION, X-LINKED 21 (OMIM:300143)
..expandMental Retardation, X-Linked 23 (C563144)
..expandMental Retardation, X-Linked 3 (C563136)
..expandMental Retardation, X-Linked 30 (C563146)
..expandMental Retardation, X-Linked 31 (C563147)
..expandMental Retardation, X-Linked 34 (C563148)
..expandMental Retardation, X-Linked 42 (C564524)
..expandMental Retardation, X-Linked 45 (C564503)
..expandMental Retardation, X-Linked 46 (C564513)
..expandMental Retardation, X-Linked 47 (C563151)
..expandMENTAL RETARDATION, X-LINKED 49 (OMIM:300114)
..expandMental Retardation, X-Linked 50 (C564713)
..expandMental Retardation, X-Linked 52 (C564502)
..expandMental Retardation, X-Linked 53 (C564533)
..expandMental Retardation, X-Linked 58 (C564566)
..expandMental Retardation, X-Linked 59 (C564470)
..expandMental Retardation, X-Linked 63 (C564522)
..expandMental Retardation, X-Linked 72 (C564547)
..expandMental Retardation, X-Linked 73 (C564528)
..expandMental Retardation, X-Linked 77 (C564511)
..expandMental Retardation, X-Linked 78 (C564489)
..expandMental Retardation, X-Linked 79 (C566876)
..expandMental Retardation, X-Linked 81 (C564515)
..expandMental Retardation, X-Linked 82 (C564496)
..expandMental Retardation, X-Linked 84 (C564501)
..expandMental Retardation, X-Linked 89 (C564036)
..expandMental Retardation, X-Linked 9 (C563137)
..expandMental Retardation, X-Linked 91 (C564482)
..expandMental Retardation, X-Linked 92 (C564483)
..expandMental Retardation, X-Linked 93 (C567066)
..expandMental Retardation, X-Linked 94 (C567479)
..expandMental Retardation, X-Linked 95 (C567470)
..expandMENTAL RETARDATION, X-LINKED 96 (OMIM:300802)
..expandMental Retardation, X-Linked Nonsyndromic (C564490)
..expandMental Retardation, X-Linked, Syndromic 10 (C564560)
..expandMental Retardation, X-Linked, Syndromic 13 (C566875)
..expandMental Retardation, X-Linked, Syndromic 14 (C567063)
..expandMental retardation, X-linked, syndromic 5 (C535773)
..expandMental Retardation, X-Linked, Syndromic 9 (C567474)
..expandMental Retardation, X-Linked, Syndromic, Jarid1c-Related (C564494)
..expandMENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE (OMIM:300799)
..expandMental Retardation, X-Linked, Syndromic, Ube2a-Related (C564069)
..expandMental Retardation, X-Linked, Syp-Related (C567584)
..expandMental Retardation, X-Linked, With Brachydactyly And Macroglossia (C567069)
..expandMental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance (C537456)
..expandMental Retardation, X-Linked, with Epilepsy (C564516)
..expandMental Retardation, X-Linked, with Isolated Growth Hormone Deficiency (C564712)
..expandMental Retardation, X-Linked, With Or Without Seizures, Arx-Related (C563150)
..expandMental Retardation, X-Linked, with Short Stature (C564527)
..expandMENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT (OMIM:300354)
..expandMental Retardation, X-Linked, With Spasticity (C566877)
..expandMental retardation-hypotonic facies syndrome, x-linked, 1 (C537457)
..expandMicrophthalmia, Syndromic 4 (C564457)
..expandMiles-Carpenter x-linked mental retardation syndrome (C537472)
..expandMucopolysaccharidosis II (D016532)
..expandOpitz-Kaveggia syndrome (C537923)
..expandOrofaciodigital syndrome, Shashi type (C537135)
..expandPartington X-linked mental retardation syndrome (C536300)
..expandPlagiocephaly and X-linked mental retardation (C537512)
..expandPpm-X Syndrome (C580387)
..expandPrieto X-linked mental retardation syndrome (C535274)
..expandPyruvate Dehydrogenase Complex Deficiency Disease (D015325) Child4
..expandRenpenning syndrome 1 (C537761)
..expandRett Syndrome (D015518) Child5
..expandRoifman syndrome (C535866)
..expandSchimke X-linked mental retardation syndrome (C536630)
..expandSiderius X-linked mental retardation syndrome (C537333)
..expandSnyder Robinson syndrome (C536678)
..expandStocco dos Santos syndrome (C537495)
..expandTranebjaerg Svejgaard syndrome (C536978)
..expandWilson-Turner X-linked mental retardation syndrome (C536708)
..expandWittwer syndrome (C536737)
..expandX-linked mental retardation Gustavson type (C536759)
..expandX-linked mental retardation type Wittwer (C536760)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:4719
Name:Glycogen Storage Disease Type IIb
Definition:An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and INTELLECTUAL DISABILITY. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.
Alternative IDs:OMIM:300257
ParentIDs:MESH:D006008|MESH:D009202|MESH:D038901|MESH:D040181
TreeNumbers:C10.597.606.643.455.562 |C14.280.238.458 |C16.320.322.201 |C16.320.565.202.449.510 |C18.452.648.202.449.510
Synonyms:Antopol Disease |Cardiomyopathies, Glycogen Storage |Cardiomyopathy, Glycogen Storage |Danon Disease |Disease, Antopol |Glycogen Storage Cardiomyopathies |Glycogen Storage Cardiomyopathy |Glycogen Storage Disease IIb |Glycogen Storage Disease Limited to the Hear
Slim Mappings:Cardiovascular disease|Genetic disease (inborn)|Metabolic disease|Nervous system disease
Reference: MedGen: D052120
MeSH: D052120
OMIM: 300257;

Genes: LAMP2;
Phenotypes
1 HP:0001423X-linked dominant inheritance
2 HP:0011675Arrhythmia
3 HP:0001640Cardiomegaly
4 HP:0100543Cognitive impairment
5 HP:0001644Dilated cardiomyopathy
6 HP:0003236Elevated circulating creatine kinase concentration
7 HP:0003458EMG: myopathic abnormalities
8 HP:0003546Exercise intolerance
9 HP:0003710Exercise-induced muscle cramps
10 HP:0003700Generalized amyotrophy
11 HP:0001263Global developmental delay
12 HP:0001639Hypertrophic cardiomyopathy
13 HP:0002375Hypokinesia
14 HP:0001249Intellectual disabilityHP:0040284
15 HP:0001685Myocardial fibrosis
16 HP:0001700Myocardial necrosis
17 HP:0001761Pes cavus
18 HP:0003812Phenotypic variability
19 HP:0003701Proximal muscle weakness
20 HP:0000505Visual impairment
21 HP:0001716Wolff-Parkinson-White syndrome
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NC_000023.11:g.(?_120431323)_(120441894_?)del3920LAMP2Likely pathogenic-1RCV000156447; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119565178119575749---C0878677 300257 Danon disease
NM_013995.2(LAMP2):c.1189G>A (p.Val397Ile)3920LAMP2Likely benign730880488RCV000157977; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119573053119573053NM_013995.2:c.1189G>ANP_054701.1:p.Val397IleNC_000023.10:g.119573053C>T-C0878544 Cardiomyopathy; C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.1093+1G>A3920LAMP2Pathogenic727504742RCV000156041; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119575584119575584NM_002294.2:c.1093+1G>ANC_000023.10:g.119575584C>T-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.1020delT (p.Gly341Glufs)3920LAMP2Pathogenic727504597RCV000155777; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119575658119575658NM_002294.2:c.1020delTNP_002285.1:p.Gly341GlufsNC_000023.10:g.119575658delA-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.999delA (p.Glu334Serfs)3920LAMP2Likely pathogenic727504557RCV000155721; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119575679119575679NM_002294.2:c.999delANP_002285.1:p.Glu334SerfsNC_000023.10:g.119575679delT-C0878677 300257 Danon disease
NM_001122606.1(LAMP2):c.961T>C (p.Trp321Arg)3920LAMP2Pathogenic104894859RCV000010664; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119575717119575717NM_001122606.1:c.961T>CNP_001116078.1:p.Trp321ArgNC_000023.10:g.119575717A>GOMIM Allelic Variant:309060.0011C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.929-1G>A3920LAMP2Likely pathogenic727504262RCV000154245; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119575750119575750NM_002294.2:c.929-1G>ANC_000023.10:g.119575750C>T-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.928G>A (p.Val310Ile)3920LAMP2Pathogenic104894858RCV000010663; RCV000157981; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:CN221809X119576454119576454NM_002294.2:c.928G>ANP_002285.1:p.Val310IleNC_000023.10:g.119576454C>TOMIM Allelic Variant:309060.0010C0878677 300257 Danon disease; CN221809 not provided
NM_002294.2(LAMP2):c.912T>G (p.Tyr304Ter)3920LAMP2Likely pathogenic-1RCV000219626; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119576470119576470NM_002294.2:c.912T>GNP_002285.1:p.Tyr304Ter-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.877C>T (p.Arg293Ter)3920LAMP2Pathogenic727503118RCV000150911; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119576505119576505NM_002294.2:c.877C>TNP_002285.1:p.Arg293TerNC_000023.10:g.119576505G>A-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.865-1G>C3920LAMP2Likely pathogenic397516752RCV000037433; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119576518119576518NM_002294.2:c.865-1G>CNC_000023.10:g.119576518C>G-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.864+3_864+6delGAGT3920LAMP2Likely pathogenic;Pathogenic397516751RCV000037432; RCV000157986; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119580154119580157NM_002294.2:c.864+3_864+6delGAGTNC_000023.10:g.119580154_119580157delACTC-C0878544 Cardiomyopathy; C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.864+1G>T3920LAMP2Pathogenic727503119RCV000150912; RCV000157972; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:CN221809X119580159119580159NM_002294.2:c.864+1G>TNC_000023.10:g.119580159C>A,NC_000023.10:g.119580159C>T-C0878677 300257 Danon disease; CN221809 not provided
NM_002294.2(LAMP2):c.851_852delTT (p.Phe284Cysfs)3920LAMP2Pathogenic727504648RCV000155911; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119580172119580173NM_002294.2:c.851_852delTTNP_002285.1:p.Phe284CysfsNC_000023.10:g.119580172_119580173delAA-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.830G>A (p.Ser277Asn)3920LAMP2Uncertain significance730880484RCV000157970; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119580194119580194NM_002294.2:c.830G>ANP_002285.1:p.Ser277AsnNC_000023.10:g.119580194C>T-C0878544 Cardiomyopathy; C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.795C>A (p.Cys265Ter)3920LAMP2Likely pathogenic;Pathogenic730880483RCV000208028; RCV000157969; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:CN221809X119580229119580229NM_002294.2:c.795C>ANP_002285.1:p.Cys265TerNC_000023.10:g.119580229G>T-C0878677 300257 Danon disease; CN221809 not provided
NM_002294.2(LAMP2):c.742-10_742-8delTCT3920LAMP2Benign730880476RCV000157956; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119580290119580292NM_002294.2:c.742-10_742-8delTCTNC_000023.10:g.119580290_119580292delAGA-C0878544 Cardiomyopathy; C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.661G>A (p.Gly221Arg)3920LAMP2Likely benign145169006RCV000037424; RCV000157955; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:CN169374X119581776119581776NM_002294.2:c.661G>ANP_002285.1:p.Gly221ArgNC_000023.10:g.119581776C>T-C0878544 Cardiomyopathy; C0878677 300257 Danon disease; CN169374 not specified
NM_001122606.1(LAMP2):c.651dupA (p.Pro218Thrfs)3920LAMP2Pathogenic730880493RCV000157985; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119581786119581786NM_001122606.1:c.651dupANP_001116078.1:p.Pro218ThrfsNC_000023.10:g.119581786dupT-C0878544 Cardiomyopathy; C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.588_589insCAACA (p.Val197Glnfs)3920LAMP2Pathogenic730880492RCV000157984; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119581848119581849NM_002294.2:c.588_589insCAACANP_002285.1:p.Val197GlnfsNC_000023.10:g.119581848_119581849insTGTTG-C0878544 Cardiomyopathy; C0878677 300257 Danon disease
NM_001122606.1(LAMP2):c.520C>T (p.Gln174Ter)3920LAMP2Pathogenic104894857RCV000010662; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119582861119582861NM_001122606.1:c.520C>TNP_001116078.1:p.Gln174TerNC_000023.10:g.119582861G>AOMIM Allelic Variant:309060.0009C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.463delA (p.Ser155Valfs)3920LAMP2Likely pathogenic193922649RCV000030113; RCV000037418; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:C0949658, Orphanet:ORPHA155, Orphanet:ORPHA99739,SNOMED CT:83978005X119582918119582918NM_002294.2:c.463delANP_002285.1:p.Ser155ValfsNC_000023.10:g.119582918delT-C0878677 300257 Danon disease; C0949658 Primary familial hypertrophic cardiomyopathy
NM_001122606.1(LAMP2):c.440T>A (p.Leu147Ter)3920LAMP2Pathogenic137852527RCV000010655; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119582941119582941NM_001122606.1:c.440T>ANP_001116078.1:p.Leu147TerNC_000023.10:g.119582941A>TOMIM Allelic Variant:309060.0002C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.294G>A (p.Trp98Ter)3920LAMP2Pathogenic-1RCV000223450; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119589315119589315NM_002294.2:c.294G>ANP_002285.1:p.Trp98Ter-C0878677 300257 Danon disease
NM_013995.2(LAMP2):c.293G>A (p.Trp98Ter)3920LAMP2Pathogenic397516740RCV000037412; RCV000157963; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:CN221809X119589316119589316NM_013995.2:c.293G>ANP_054701.1:p.Trp98Ter-C0878677 300257 Danon disease; CN221809 not provided
NM_002294.2(LAMP2):c.277G>A (p.Gly93Arg)3920LAMP2Likely benign;Uncertain significance727504953RCV000156356; RCV000157962; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:CN169374X119589332119589332NM_002294.2:c.277G>ANP_002285.1:p.Gly93ArgNC_000023.10:g.119589332C>T-C0878544 Cardiomyopathy; C0878677 300257 Danon disease; CN169374 not specified
NM_001122606.1(LAMP2):c.217dupA (p.Thr73Asnfs)3920LAMP2Likely pathogenic397516739RCV000037411; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119589392119589392NM_001122606.1:c.217dupANP_001116078.1:p.Thr73AsnfsNC_000023.10:g.119589392dupT-C0878677 300257 Danon disease
NM_001122606.1(LAMP2):c.191delT (p.Val64Glufs)3920LAMP2Likely pathogenic397516738RCV000037410; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119589418119589418NM_001122606.1:c.191delTNP_001116078.1:p.Val64GlufsNC_000023.10:g.119589418delA-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.183+1G>A3920LAMP2Likely pathogenic727503120RCV000150913; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119590505119590505NM_002294.2:c.183+1G>ANC_000023.10:g.119590505C>T-C0878677 300257 Danon disease
NM_001122606.1(LAMP2):c.183T>A (p.Tyr61Ter)3920LAMP2Likely pathogenic397516736RCV000037407; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119590506119590506NM_001122606.1:c.183T>ANP_001116078.1:p.Tyr61TerNC_000023.10:g.119590506A>C,NC_000023.10:g.119590506A>T-C0878677 300257 Danon disease
NM_001122606.1(LAMP2):c.183T>G (p.Tyr61Ter)3920LAMP2Likely pathogenic397516736RCV000037408; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119590506119590506NM_001122606.1:c.183T>GNP_001116078.1:p.Tyr61TerNC_000023.10:g.119590506A>C,NC_000023.10:g.119590506A>T-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.128_129dupAT (p.Ala44Metfs)3920LAMP2Likely pathogenic730880344RCV000154670; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119590560119590561NM_002294.2:c.128_129dupATNP_002285.1:p.Ala44MetfsNC_000023.10:g.119590560_119590561dupAT-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.121delT (p.Cys41Alafs)3920LAMP2Pathogenic727504600RCV000155846; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119590568119590568NM_002294.2:c.121delTNP_002285.1:p.Cys41AlafsNC_000023.10:g.119590568delA-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.65-2A>G3920LAMP2Pathogenic397516743RCV000037416; NMedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119590626119590626NM_002294.2:c.65-2A>GNC_000023.10:g.119590626T>C-C0878677 300257 Danon disease
NM_002294.2(LAMP2):c.-23_-15delGTCGCCGCC3920LAMP2Benign;Likely benign193922648RCV000030112; RCV000037402; RCV000157958; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006; MedGen:C0949658, Orphanet:ORPHA155, Orphanet:ORPHA99739,SNOMED CT:83978005; MedGen:CN169374X119603039119603047NM_002294.2:c.-23_-15delGTCGCCGCCNC_000023.10:g.119603039_119603047delGGCGGCGAC-C0878544 Cardiomyopathy; C0878677 300257 Danon disease; CN169374 not specified; C0949658 Primary familial hypertrophic cardiomyopathy
NM_001122606.1(LAMP2):c.-26_-15dupGCCGTCGCCGCC3920LAMP2Uncertain significance730880495RCV000157988; NMedGen:C0878544, Orphanet:ORPHA167848,SNOMED CT:85898001; MedGen:C0878677,OMIM:300257,ORPHA:34587,SNOMED CT:419097006X119603039119603050NM_001122606.1:c.-26_-15dupGCCGTCGCCGCCNC_000023.10:g.119603039_119603050dupGGCGGCGACGGC-C0878544 Cardiomyopathy; C0878677 300257 Danon disease